DK150304C - Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf

Info

Publication number
DK150304C
DK150304C DK227782A DK227782A DK150304C DK 150304 C DK150304 C DK 150304C DK 227782 A DK227782 A DK 227782A DK 227782 A DK227782 A DK 227782A DK 150304 C DK150304 C DK 150304C
Authority
DK
Denmark
Prior art keywords
propoxymethyl
guanine
dihydroxy
analogue
preparation
Prior art date
Application number
DK227782A
Other languages
Danish (da)
English (en)
Other versions
DK227782A (da
DK150304B (da
Inventor
Julien P Verheyden
John C Martin
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23017790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK150304(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK227782A publication Critical patent/DK227782A/da
Priority to DK504183A priority Critical patent/DK149001C/da
Publication of DK150304B publication Critical patent/DK150304B/da
Application granted granted Critical
Publication of DK150304C publication Critical patent/DK150304C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK227782A 1981-05-21 1982-05-19 Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf DK150304C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK504183A DK149001C (da) 1981-05-21 1983-11-03 9-substituerede n2-acylguaniner eller syreadditionssalte eller uorganiske metalsalte deraf

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26721081 1981-05-21
US06267210 US4355032B2 (en) 1981-05-21 1981-05-21 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent

Publications (3)

Publication Number Publication Date
DK227782A DK227782A (da) 1982-11-22
DK150304B DK150304B (da) 1987-02-02
DK150304C true DK150304C (da) 1988-01-04

Family

ID=23017790

Family Applications (2)

Application Number Title Priority Date Filing Date
DK227782A DK150304C (da) 1981-05-21 1982-05-19 Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf
DK504183A DK149001C (da) 1981-05-21 1983-11-03 9-substituerede n2-acylguaniner eller syreadditionssalte eller uorganiske metalsalte deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK504183A DK149001C (da) 1981-05-21 1983-11-03 9-substituerede n2-acylguaniner eller syreadditionssalte eller uorganiske metalsalte deraf

Country Status (33)

Country Link
US (1) US4355032B2 (ja)
EP (1) EP0066208B1 (ja)
JP (2) JPS57203086A (ja)
KR (1) KR890004663B1 (ja)
AR (1) AR244227A1 (ja)
AT (1) ATE15899T1 (ja)
AU (1) AU572086B2 (ja)
BR (1) BR8202931A (ja)
CA (3) CA1305141C (ja)
CS (4) CS235042B2 (ja)
DD (2) DD213218A5 (ja)
DE (1) DE3266644D1 (ja)
DK (2) DK150304C (ja)
ES (7) ES512414A0 (ja)
FI (1) FI73682C (ja)
GR (1) GR76459B (ja)
HK (1) HK67088A (ja)
HU (2) HU188000B (ja)
IE (1) IE53731B1 (ja)
IL (1) IL65836A (ja)
IN (1) IN156469B (ja)
LU (1) LU88334I2 (ja)
MY (1) MY8700793A (ja)
NL (2) NL930022I1 (ja)
NO (2) NO161740C (ja)
NZ (1) NZ200691A (ja)
PH (1) PH17975A (ja)
PL (4) PL136579B1 (ja)
PT (1) PT74934B (ja)
RO (2) RO84860B (ja)
SG (1) SG81687G (ja)
SU (1) SU1176841A3 (ja)
ZA (1) ZA823532B (ja)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508898A (en) * 1980-09-16 1985-04-02 Ogilvie Kelvin K Antiviral triazine compounds
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4507305A (en) * 1981-05-21 1985-03-26 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
AT380252B (de) * 1981-08-11 1986-05-12 Wellcome Found Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen
NZ201662A (en) * 1981-08-26 1986-07-11 Merck & Co Inc 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
US4621140A (en) * 1984-02-23 1986-11-04 Syntex (U.S.A.) Inc. Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0190123A1 (en) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Immunoregulatory and anti-viral compound
ES8705889A1 (es) * 1984-12-12 1987-06-01 Syntex Inc Un metodo para preparar eteres alcaximetilicos y esteres alcoximetilicos de derivados de guananina.
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4642346A (en) * 1985-06-24 1987-02-10 Syntex (U.S.A.) Inc. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
AU618436B2 (en) * 1988-12-19 1991-12-19 Wellcome Foundation Limited, The Antiviral cytosine and guanine derivatives
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
ES2132411T3 (es) * 1993-06-23 1999-08-16 Merrell Pharma Inc Derivados nucleosidicos carbo-aciclicos como agentes antivirasicos y antineoplasicos.
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
IN179493B (ja) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
EP0976751A1 (en) * 1996-04-09 2000-02-02 Lupin Laboratories Limited A process for the isomerisation of an N-7 isomer into an N-9 isomer useful in the synthesis of acyclic nucleosides
US5852208A (en) * 1996-08-30 1998-12-22 Dixie Chemical Company, Inc. Method of producing compounds containing acyloxyalkoxy groups from alcohols
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20060189565A1 (en) * 2002-10-22 2006-08-24 Mathur Rajeev S Pharmaceutical compositions of ganciclovir
WO2004039808A2 (en) * 2002-10-31 2004-05-13 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
WO2004048380A1 (en) * 2002-11-22 2004-06-10 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
CN105596356A (zh) 2003-01-14 2016-05-25 吉里德科学公司 用于联合抗病毒治疗的组合物和方法
ITMI20031202A1 (it) * 2003-06-13 2004-12-14 Lyogen Ltd Forma di cristallina del ganciclovir
US20070129385A1 (en) * 2003-08-28 2007-06-07 Sharma Mukesh K Amorphous valganciclovir hydrochloride
JP4746866B2 (ja) * 2004-11-19 2011-08-10 Ｔｃｍ株式会社 キャリッジ用ガタ抑制装置
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
WO2009120358A1 (en) * 2008-03-27 2009-10-01 Nektar Therapeutics Oligomer-nitrogenous base conjugates
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
KR20110104074A (ko) 2008-12-23 2011-09-21 파마셋 인코포레이티드 퓨린 뉴클레오시드의 합성
PA8855601A1 (es) * 2008-12-23 2010-07-27 Forformidatos de nucleósidos
US8551973B2 (en) * 2008-12-23 2013-10-08 Gilead Pharmasset Llc Nucleoside analogs
CN101851239B (zh) * 2009-04-03 2012-11-28 上海益威实业有限公司 一种更昔洛韦的回收方法
CA2794671C (en) 2010-03-31 2018-05-01 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
WO2012154698A2 (en) * 2011-05-06 2012-11-15 Mckenna Charles E Method to improve antiviral activity of nucleotide analogue drugs
CN102627643B (zh) * 2012-04-10 2014-01-08 常州康丽制药有限公司 更昔洛韦的精制方法
WO2014068265A1 (en) 2012-10-29 2014-05-08 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
JP6237779B2 (ja) * 2012-11-03 2017-11-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害薬
CN103059023B (zh) * 2012-12-31 2015-09-30 浙江车头制药股份有限公司 一种制备更昔洛韦晶型ⅱ的方法
US9486530B1 (en) 2013-08-30 2016-11-08 Exela Pharma Sciences, LLC Ganciclovir compositions and related methods
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN113476413B (zh) * 2021-08-09 2022-06-28 海南海灵化学制药有限公司 一种注射用更昔洛韦钠冻干粉的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU7938482A (en) * 1980-12-22 1982-07-20 Astra Lakemedel Aktiebolag Novel derivatives of guanine
AT380252B (de) * 1981-08-11 1986-05-12 Wellcome Found Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen

Also Published As

Publication number Publication date
RO84860B (ro) 1984-10-30
ES8404355A1 (es) 1984-05-01
PL246770A1 (en) 1984-08-27
PL242100A1 (en) 1984-04-24
PT74934B (en) 1984-05-08
RO87387B (ro) 1985-08-31
SU1176841A3 (ru) 1985-08-30
ES8601204A1 (es) 1985-11-16
IL65836A (en) 1991-04-15
ES520849A0 (es) 1984-11-01
PL136332B1 (en) 1986-02-28
NZ200691A (en) 1986-11-12
NO821676L (no) 1982-11-22
ATE15899T1 (de) 1985-10-15
DK227782A (da) 1982-11-22
CA1305141C (en) 1992-07-14
PH17975A (en) 1985-02-22
AR244227A1 (es) 1993-10-29
NO161740C (no) 1989-09-20
SG81687G (en) 1989-07-07
PL242101A1 (en) 1984-07-16
HK67088A (en) 1988-09-02
GR76459B (ja) 1984-08-10
PL136004B1 (en) 1986-01-31
DK504183D0 (da) 1983-11-03
CA1305140C (en) 1992-07-14
ES529383A0 (es) 1986-05-16
IE821210L (en) 1982-11-21
PL136637B1 (en) 1986-03-31
FI73682B (fi) 1987-07-31
US4355032B1 (ja) 1983-06-14
ZA823532B (en) 1983-03-30
PL136579B1 (en) 1986-02-28
HU188000B (en) 1986-03-28
ES8505681A1 (es) 1985-06-16
CS235044B2 (en) 1985-04-16
DK150304B (da) 1987-02-02
EP0066208B1 (en) 1985-10-02
BR8202931A (pt) 1983-05-03
NL930022I1 (nl) 1993-05-03
CA1305139C (en) 1992-07-14
DK149001C (da) 1988-11-28
ES8507549A1 (es) 1985-09-16
IN156469B (ja) 1985-08-10
KR890004663B1 (ko) 1989-11-24
HU186514B (en) 1985-08-28
DD203052A5 (de) 1983-10-12
ES8500276A1 (es) 1984-11-01
NO1994005I1 (no) 1994-07-29
AU572086B2 (en) 1988-05-05
ES524899A0 (es) 1985-09-16
FI73682C (fi) 1987-11-09
CS235043B2 (en) 1985-04-16
MY8700793A (en) 1987-12-31
ES529384A0 (es) 1987-01-01
AU8389282A (en) 1982-11-25
NO161740B (no) 1989-06-12
IL65836A0 (en) 1982-08-31
ES524900A0 (es) 1985-11-16
DK149001B (da) 1985-12-16
FI821794A0 (fi) 1982-05-20
PT74934A (en) 1982-06-01
US4355032B2 (en) 1990-10-30
JPS57203086A (en) 1982-12-13
NL930139I2 (nl) 1997-07-01
JPH04217983A (ja) 1992-08-07
DK504183A (da) 1983-11-03
DD213218A5 (de) 1984-09-05
ES8606869A1 (es) 1986-05-16
NL930139I1 (nl) 1993-11-01
RO87387A (ro) 1985-08-31
US4355032A (en) 1982-10-19
LU88334I2 (fr) 1994-09-09
ES533821A0 (es) 1985-06-16
JPH0529399B2 (ja) 1993-04-30
CS235018B2 (en) 1985-04-16
RO84860A (ro) 1984-09-29
EP0066208A1 (en) 1982-12-08
DE3266644D1 (en) 1985-11-07
PL236521A1 (en) 1984-01-02
IE53731B1 (en) 1989-02-01
ES512414A0 (es) 1984-05-01
CS235042B2 (en) 1985-04-16
JPH046195B2 (ja) 1992-02-05
ES8701496A1 (es) 1987-01-01
KR830010112A (ko) 1983-12-26

Similar Documents

Publication Publication Date Title
DK150304C (da) Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf
DK161770C (da) Analogifremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK160314C (da) Analogifremgangsmaade til fremstilling af bicycliske pyrimidin-5-on-derivater og farmaceutisk acceptable salte deraf
DK149449C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater eller farmaceutisk acceptable salte deraf
DK163359C (da) Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf
DK148711C (da) Analogifremgangsmaade til fremstilling af 1-(3-mercapto-2-methylpropanoyl)-prolyl-aminosyre-derivater, optiske isomere deraf eller farmaceutisk acceptable salte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK148537C (da) Analogifremgangsmaade til fremstilling af 3-aminopyridazinforbindelser eller farmaceutisk acceptable salte deraf
DK149856C (da) Fremgangsmaade til fremstilling af 1,3-di- eller 1,3,8-trisubstituerede xanthiner eller fysiologisk acceptable salte deraf
DK163181C (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
DK162166C (da) Analogifremgangsmaade til fremstilling af (2s)-isomere af 2-oe4-(2-hydroxycyclopentan-1-ylmethyl)phenylaapropionsyre eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK155670C (da) Analogifremgangsmaade til fremstilling af sesquiterpenderivater eller farmaceutisk acceptable salte deraf
DK149269C (da) Analogifremgangsmaade til fremstilling af beta-mono- eller -difluormethyl-beta-alanin-derivater eller farmaceutisk acceptable salte eller optiske isomere deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK162102C (da) Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK151254C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00004, 930104

CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1993 00004, 930104

PUP Patent expired